Gilead Sciences
GILD
#131
Rank
C$226.60 B
Marketcap
C$182.52
Share price
-0.82%
Change (1 day)
17.93%
Change (1 year)

Gilead Sciences (GILD) - Net assets

Net assets on the balance sheet as of March 2026 : C$32.84 Billion

According to Gilead Sciences's latest financial reports the company has C$32.84 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Gilead Sciences - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$C$30.97 B12.16%
2024-12-31$C$27.61 B-8.47%
2023-12-31$C$30.17 B4.84%
2022-12-31$C$28.77 B7.21%
2021-12-31$C$26.84 B15.55%
2020-12-31$C$23.23 B-21.46%
2019-12-31$C$29.58 B0.85%
2018-12-31$C$29.33 B13.81%
2017-12-31$C$25.77 B-0.95%
2016-12-31$C$26.02 B-1.86%
2015-12-31$C$26.51 B44.43%
2014-12-31$C$18.35 B46.83%
2013-12-31$C$12.50 B31.74%
2012-12-31$C$9.49 B35.86%
2011-12-31$C$6.98 B14.15%
2010-12-31$C$6.11 B-10.6%
2009-12-31$C$6.84 B26.06%
2008-12-31$C$5.42 B51.18%
2007-12-31$C$3.59 B65.07%
2006-12-31$C$2.17 B-38.28%
2005-12-31$C$3.52 B56.87%
2004-12-31$C$2.24 B72.71%
2003-12-31$C$1.30 B44.18%
2002-12-31$C$0.90 B25.2%
2001-12-31$C$0.72 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
C$113.79 B 246.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$126.71 B 285.83%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-C$9.27 Billion-128.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$43.73 B 33.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.88 B-60.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$26.14 B-20.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$3.75 B-88.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$27.13 B-17.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$64.38 B 96.03%๐Ÿ‡บ๐Ÿ‡ธ USA